BLRX

BioLineRX

17 hedge funds and large institutions have $9.16M invested in BioLineRX in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SM
1
Senvest Management
New York
$3.69M 2,278,995 +682,628 +43%
BI
2
BVF Inc
California
$2.43M 1,501,000
O
3
OrbiMed
New York
$1.84M 1,135,000
Deutsche Bank
4
Deutsche Bank
Germany
$522K 322,846 +130,996 +68%
OM
5
Opaleye Management
Massachusetts
$405K 250,000 -240,000 -49%
BCA
6
Benchmark Capital Advisors
New York
$65K 40,000
NFG
7
Next Financial Group
Texas
$46K 28,500 +9,000 +46%
Renaissance Technologies
8
Renaissance Technologies
New York
$44K 26,878 -101,222 -79%
Morgan Stanley
9
Morgan Stanley
New York
$44K 27,175 +16,900 +164%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$29K 17,800
PNC Financial Services Group
11
PNC Financial Services Group
Pennsylvania
$16K 10,000 +10,000 New
CCB
12
Cutter & Co Brokerage
Missouri
$16K 10,000 +10,000 New
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$3K 2,000
Wells Fargo
14
Wells Fargo
California
$2K 1,000
SM
15
Sabby Management
Florida
$1.51K 928,758 +928,758 New
SFM
16
Sphera Funds Management
Israel
-193,284 Closed
TRCT
17
Tower Research Capital (TRC)
New York
$0 110 -4,216 -97%
Ameriprise
18
Ameriprise
Minnesota
-291 Closed
Citigroup
19
Citigroup
New York
$0 45 +45 New